Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kelan (Shanghai) Pharmaceutical Technology

Request full access

Developing novel drugs targeting metabolic diseases and oncology through advanced R&D pipelines

ChinaFounded 2021Biotech & Life Sciences

About Kelan (Shanghai) Pharmaceutical Technology

Cholesgen operates in the pharmaceutical sector, focusing on the research and development of novel drugs targeting metabolic diseases and oncology. The company leverages a unique R&D perspective, integrating principles of biochemistry, disease biology, medicinal chemistry, and translational medicine. Its founding team comprises R&D experts from leading domestic and international pharmaceutical companies, alongside researchers from top Chinese institutes. Cholesgen's advisory team includes senior scientists and professors specializing in metabolism, life sciences, and medicinal chemistry. The company recently secured over 100 million RMB in Series A financing, which will be used to accelerate the development of its core drug pipeline, expand its R&D team, and enhance external collaborations. Cholesgen's business model revolves around building differentiated R&D pipelines based on new mechanisms in metabolic and oncology research, aiming to develop drugs for new targets. The company serves clients in the healthcare and pharmaceutical markets, generating revenue through the development and potential commercialization of its drug candidates.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
21.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Drug Development, Cardiology and cardiovascular, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Feb 2025 $14M $55M SDIC Venture Capital ↗
SERIES A✓Equity / VC Jun 2023 $14M $55M Gaorong Ventures · CICC · Dawu Venture Capital · Trinity Innovation Fund ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Kelan (Shanghai) Pharmaceutical Technology website traffic

Latest recorded traffic for Kelan (Shanghai) Pharmaceutical Technology is 60 monthly website visits, up 0% over the last three months.

Latest monthly visits60 3-month web change0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Kelan (Shanghai) Pharmaceutical Technology in its local ecosystem

Live from Dealroom

The Kelan (Shanghai) Pharmaceutical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Gaorong Ventures
  • CICC
  • Dawu Venture Capital
  • Trinity Innovation Fund
  • Nanwan Baiao Fund
  • SDIC Venture Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kelan (Shanghai) Pharmaceutical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kelan (Shanghai) Pharmaceutical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.